In light of the recent news on the Oxford Covid-19 vaccine, John Rountree, was invited on CNBC to discuss the outlook.
Discover John’s previous comments on the vaccine here.
Media
Oxford vaccine news is very encouraging (CNBC)
In light of the recent news on the Oxford Covid-19 vaccine, John Rountree, was invited on CNBC to discuss the outlook.
Discover John’s previous comments on the vaccine here.
Related
Media
How European MidPharmas have grown profits
DiscoverAstraZeneca sacrifices revenue with a no-profit Covid-19 vaccine (Daily Mail)
DiscoverOxford vaccine news is very encouraging (CNBC)
Discover